Home Gilead stock hits record after hepatitis C drug's success in Europe
 

Keywords :   


Gilead stock hits record after hepatitis C drug's success in Europe

2013-11-22 23:55:24| Biotech - Topix.net

Gilead Sciences said Friday that an advisory committee in the European Union is recommending that its hepatitis C drug Sovaldi receive marketing approval.

Tags: in stock record europe

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
More »